"Triazoles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D014230
|
MeSH Number(s) |
D03.383.129.799
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Triazoles".
Below are MeSH descriptors whose meaning is more specific than "Triazoles".
This graph shows the total number of publications written about "Triazoles" by people in this website by year, and whether "Triazoles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2008 | 1 | 1 | 2 |
2009 | 0 | 2 | 2 |
2010 | 1 | 0 | 1 |
2012 | 2 | 0 | 2 |
2013 | 3 | 0 | 3 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 3 | 0 | 3 |
2017 | 40 | 17 | 57 |
2018 | 42 | 13 | 55 |
2019 | 17 | 4 | 21 |
2020 | 5 | 4 | 9 |
2021 | 3 | 4 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Triazoles" by people in Profiles.
-
Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States. mBio. 2021 08 31; 12(4):e0180321.
-
Drug repurposing of triazoles against mucormycosis using molecular docking: A short communication. Comput Biol Med. 2021 09; 136:104722.
-
Subtherapeutic posaconazole prophylaxis in a gastric bypass patient following hematopoietic stem cell transplantation. Am J Health Syst Pharm. 2021 07 09; 78(14):1282-1286.
-
Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease. Proteins. 2021 11; 89(11):1425-1441.
-
Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran. Mycoses. 2021 Oct; 64(10):1238-1252.
-
New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2. Bioorg Chem. 2021 09; 114:105117.
-
Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo. Antiviral Res. 2021 08; 192:105115.
-
Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase. Sci Rep. 2021 05 13; 11(1):10290.
-
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors. Eur J Med Chem. 2021 Oct 05; 221:113494.
-
Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents. Expert Opin Ther Pat. 2021 Apr; 31(4):339-350.